Background and Purpose-After pneumonectomy or lobectomy, at least 1 blind pulmonary vein is left with potential risk of postoperative thromboembolic incidents. We investigated the risk of stroke within this population compared with background and pulmonary wedge resections controls. Methods-We identified 12 965 patients with pneumonectomy or lobectomy and 6400 patients with wedge resection using data from Danish nationwide registries from 1996 to 2016. In multivariate Poisson regression analysis, we estimated incidence rate ratios of stroke for patients undergoing lobectomy or pneumonectomy versus background population controls and patients who underwent wedge resection. We stratified our analysis by days: 0 to 30, 31 to 90, 91 to 180, and 180 to 365 after surgery and performed a subgroup analysis in patients with lung cancer. Results-The incidence rate of stroke was 10.6 per 1000 person-years for time exposed for pneumonectomy or lobectomy and 2.3 per 1000 person-years for patients not exposed for pneumonectomy or lobectomy. In the 0-to 30-day multivariate Poisson regression analysis, compared with the background population, pneumonectomy or lobectomy was associated with an increased risk of stroke both patients with and without atrial fibrillation (incidence rate ratios [IRR]) of 4.66 (95% CI, 2.04-7.12) and 5.43 (95% CI, 3.99-7.41), respectively. Similarly, in patients with lung cancer, the first 30 days after pneumonectomy or lobectomy remained a risk factor for stroke for patients with (IRR, 2.94; 95% CI, 1.39-6.25) and for patients without atrial fibrillation (IRR, 2.56; 95% CI, 1.86-3.59).When compared with wedge resection, 0 to 30 days after lobectomy or pneumonectomy was also associated with increased risk of stroke (IRR, 2.63; 95% CI, 1.19-5.81); however, this association was insignificant in patients with lung cancer (IRR, 2.98; 95% CI, 0.72-12.29). Conclusions-Patients undergoing pneumonectomy or lobectomy had an increased 30 days risk of stroke. Whether the pulmonary vein stump is a risk factor for stroke and whether preventive strategies are relevant require further investigation.
S
troke is known to be a rare but serious complication to resection for nonsmall cell lung cancer in the postoperative phase after surgery. 1 Recent cohort studies and case reports of patients undergoing elective lobectomy have suggested that thrombosis of the left superior pulmonary vein stump may be an underlying cause of both cerebral infarction, [2] [3] [4] as well as other vital organ infarction. 5, 6 Nevertheless, after pneumonectomy and lobectomy, the incidence of stroke is largely unknown, and currently, pulmonary vein stump thrombosis or anticoagulant therapy is not offered Nonsmall cell lung cancer is the most common type of cancer with an annual incidence of almost 2 million cases worldwide. 7 Early detection and surgical resection offers the best opportunity for survival, and patients who survive surgery and postoperative complications 1 may have a long remaining postoperative lifetime. Therefore, identification and quantification of magnitude of potential short-and long-term complications, as well as potential preventive measures, are warranted.
In patients with lung cancer, lobectomy or pneumonectomy is the preferred type of surgery, 8 and wedge resection is primarily offered to patients with large cardiopulmonary comorbidity burden or expected insufficient postoperative lung function. 9 Indications for wedge resection also include solitary metastases from other cancer types and benign lung disease and is, therefore, not as lobectomy primarily performed in patients with lung cancer. 10 Several case reports describe the finding of a thrombus in the pulmonary vein stump. 2, 3 Likewise, arterial embolic incidents after lobectomy are described casuistic. 5, 6, 11 Recently, a causal link between these events was suggested by 2 case reports. 4, 12 In combination, this study and case reports suggest a potential causal relation between thrombus formation and arterial embolic incidents after lobectomy and further suggest that the incidence of both should be explored. 12 Thus, the incidence and risk factors of stroke and other embolic incidents after pneumonectomy or lobectomy is on a large scale unknown, and currently, anticoagulant therapy is not offered as a part of standard care after lobectomy or pneumonectomy.
Incidence of Stroke After Pneumonectomy and Lobectomy
The objective of this study was, therefore, to investigate whether pneumonectomy or lobectomy are associated with increased risk of stroke. A potential increased risk of stroke after lobectomy/pneumonectomy may arise from complications to lung surgery in general or merely be caused by comorbidity burden in patients with lung cancer. Therefore, we compared pneumonectomy or lobectomy both to (1) wedge resection controls and (2) background population controls both in the general population and in patients with lung cancer. We stratified our analysis by time since resection and estimated the cumulative incidence of stroke after lobectomy or pneumonectomy and wedge resection.
Methods

Data Sources
We identified our study population from the entire Danish population alive and above 18 years of age from 1996 to 2016. All data used in this analysis is publicly available through Statistics Denmark.
By using the unique civil registration number, administered to all Danish citizens, we were able to link several nationwide registries. We identified the cohort from the civil registration system holding information on date of birth, death, sex, migration, and socioeconomic status. 13 We retrieved information on hospital admissions from the Danish National Patient Registry, holding information on all hospitalizations since 1977, including admission and discharge dates, discharge diagnosis, procedure codes, and surgical procedures. 14, 15 From the Danish prescription registry, we obtained information according to claimed prescriptions, which since 1995 was registered according to the Anatomic Therapeutic Chemical classification. 16, 17 
Study Populations
The population consisted of all Danish citizens, who entered consecutively from January 1, 1996 to December 31, 2016. Each individual entered the study at the last of the following events: January 1, 1996, the individuals 18th birthday, or the date of immigration to Denmark and followed until the first of the following: date of stroke, death, or emigration or December 31, 2016. We excluded patients with a history of stroke before entry.
Outcomes
Our primary outcome was stroke (International Classification of Diseases, Tenth Revision (ICD-10) and Health-related problems: DI63 DI64 and ICD-8: 433 or 434).
As a secondary outcome, we explored the incidence of first arterial embolic event stroke and including stroke transient cerebral ischemia, renal infarction and peripheral arterial embolism (ICD-10: DI63, DI64, DI74, DG458, DG459 or DN280 and ICD-8: 433,434, 435, or 444).
Exposure
We defined our exposure as any pneumonectomy or lobectomy from the following Nordic Medical-Statistical Committee codes KGDC (except KGDC96-97) and KGDD (except KGDD20).
Covariates
We used directed acyclic graphs to identify potential covariates ( Figure I in the online-only Data Supplement). 18 Comorbidities, peripheral arteriosclerotic disease, ischemic heart disease, renal disease, chronic obstructive pulmonary disease, heart failure, nonmetastatic cancer, metastatic cancer, lung cancer, hyperlipidemia, and hypertension were identified by in-and out-patient diagnoses, as well as by prescriptions, and we updated these covariates in a time-dependent manner.
Medical treatment included antidiabetic medicine, antihypertensive treatment, lipid lowering, anticoagulants, and prescriptions for chronic obstructive pulmonary disease.
Hypertension was defined as the presence of prescription of at least 2 of the following drugs: alfa-adrenergic blockers, β-blockers, nonloop diuretics, calcium channel blockers, vasodilators, and reninangiotensin inhibitors, as previously validated. 19 Diabetes mellitus, hypertension, and heart failure were defined to be present by the first time of either diagnosis or prescription.
We defined wedge resections by ICD-10 KGDB10 and KGDB11.
Statistical Analysis
We modeled pneumonectomy or lobectomy as a time-dependent exposure variable. Each individual contributed with disease-free exposure time, until date of surgery, and from this day onward with time exposed. The data was split using the Lexis-macro (http://192.38.117.59/ wbxc/Lexis/Lexis.sas) and used 2 time scales: 5-year intervals since January 1, 1996, and years since lobectomy/pneumonectomy (1, 2, and >2 years after lobectomy/pneumonectomy). The incidence rates of stroke are presented per 1000 person-years. The incidence rate ratios (IRR) for stroke after pneumonectomy or lobectomy are calculated using Poisson regression models. We stratified our analysis by days 0 to 30, 31 to 90, 91 to 180, and 180 to 365 after surgery. Atrial fibrillation is a major risk factor for stroke and is moreover common after lobectomy with 10% to 30% experiencing postoperative arrhythmias. 10, 20 We, therefore, performed a predefined interaction analysis and stratified on atrial fibrillation when interaction was present. We performed a subgroup analysis only including patients with lung cancer. In similar Poisson regression analysis, pneumonectomy or lobectomy and wedge resection were compared. In addition, we performed an analysis of the association between lobectomy/pneumonectomy and arterial embolic events in general.
As time-dependent covariates, the following potential confounders were included: age, sex, anticoagulant therapy, calendar year, hypertension, peripheral artery disease, ischemic heart disease, heart failure, metastatic cancer, nonmetastatic cancer, and chronic obstructive pulmonary disease.
Lastly, we estimated the cumulative incidence of stroke after (1) lobectomy or pneumonectomy with death as competing risk and (2) wedge resection with both death and lobectomy or pneumonectomy as competing risks.
As sensitivity analysis, we included an analysis of the E value for each 0-to 30-day estimate to quantify the robustness to unmeasured confounding of the association. A large E value implies that considerable unmeasured confounding would have to be present to explain the effect estimate. 21 All data management and statistical analysis were performed using SAS 9.4 institute and R 3.5.0. 
Results
A total of 6 319 816 patients alive (≥18 years) were identified. We excluded 178 092 (2.8%) nonresident individuals, resulting in a population of 6 141 724 individuals. After further exclusion of 29 238 (0.5%) individuals, with a history of stroke before the date of entry, 6 112 486 individuals were included in the study. During a median follow-up of 18 years, there were 280 464 strokes, 12 965 pneumonectomies or lobectomies, and 6400 wedge resections. Of these, 1144 patients had sequential lobectomy or pneumonectomy and a wedge resection in various order. In 93 176 patients with lung cancer, 11 944 received pneumonectomy or lobectomy and 2370 received wedge resection. Table 1 shows time at risk for characteristics after pneumonectomy or lobectomy. Table 2 shows incidence rates of stroke across subgroups after pneumonectomy or lobectomy.
Incidence Rate of Stroke
Overall, the incidence of stroke was higher after lobectomy or pneumonectomy compared with before surgery, and the risk was highest in the first 30 days after surgery. This difference persisted across sex and age groups, and even among patients with atrial fibrillation, the incidence rate was markedly higher within 30 days after pneumonectomy or lobectomy.
Incidence Rate Ratios of Stroke
In a multivariate Poisson regression model the 30-day incidence rate ratio (IRR) of stroke was 5.36 (95% CI, 4.04-7.12) for patients who underwent lobectomy or pneumonectomy compared with background population controls not undergoing lobectomy or pneumonectomy ( Figure 1A ). IRR day 31 to 90 was 2.57 (95% CI, 1.92-3.45) and 91 to 180 days IRR was 1.79 (95% CI, 1.34-2.39), days 181 to 365 IRR was1.23 (95% CI, 0.95-1.59).
Incidence Rate Ratios of Stroke Stratified on Atrial Fibrillation
There was no interaction with day 0 to 30 after lobectomy or pneumonectomy and atrial fibrillation (P value=0.08); however, for 31 to 90 days, 91 to 180 days, and 181 to 365 days to 1 year, the P value for interaction was <0.01. Pneumonectomy or lobectomy was associated with an increased 30-day risk of stroke both in patients with atrial fibrillation (IRR, 4.66; 95% CI, 2.33-9.32) and in patients without atrial fibrillation (IRR, 5.43; 95% CI, 3.99-7.41) compared with time before surgery. In patients without atrial fibrillation, a significantly increased risk of stroke persisted during the first year after surgery (IRR, 2.89, 95% CI, 2.13-9.93; IRR, 2.89, 95% CI, 2.13-3.93; IRR, 1.97, 95% CI, 1.45-2.68; and IRR, 1.38, 95% CI, 1.05-1.82 for 31 to 90, 91 to 180, and 181 to 365 days, respectively; Figure 1B ). In patients with atrial fibrillation, only days 0 to 30 were associated with increased risk of stroke. Figure 1C ). In patients without atrial fibrillation, days 31 to 90 were associated with increased risk of stroke IRR, 1.53 (95% CI, 1.12-2.09), whereas remaining time periods were not.
Pneumonectomy or Lobectomy Compared With Wedge Resections
We compared wedge resections with pneumonectomy and lobectomy stratified on time since surgery both in the background population and in patients with lung cancer. We found no interaction with atrial fibrillation. Results are shown in Figure 2 . Figure II in the online-only Data Supplement shows that the cumulative incidence of stroke after lobectomy or pneumonectomy was higher than for patients who underwent wedge resection in the first year after surgery. Figure 3 ). Figure III in the online-only Data Supplement shows the IRRs of embolic events after pneumonectomy or lobectomy compared with wedge resection.
Incidence Rate Ratios of Other Arterial Embolic Events
Sensitivity Analysis
In a sensitivity analysis, we moved the first date of atrial fibrillation diagnosis 60 days forward to investigate whether atrial fibrillation, with delayed identification and diagnosis, could be the underlying cause of increased risk of stroke. However, pneumonectomy and lobectomy remained a risk factor for stroke, and the 30-day risk of stroke remained high RR, 5.17 (95% CI, 3.90-6.86).
We calculated the E value for 0-to 30-day IRRs for lobectomy or pneumonectomy compared with time without surgery and compared with wedge resection. E values were large (compared with [1] general population: 10.3, and [2] wedge resection: 4.7). Results are shown in Table I in the online-only Data Supplement.
Discussion
In this nationwide study encompassing >6 million Danish citizens, we found a high incidence of stroke in the first 30 days after lobectomy or pneumonectomy. Moreover, in multivariate analysis, we found that pneumonectomy or lobectomy was a risk factor for stroke primarily in the first 30 days after surgery. Postoperative atrial fibrillation and the presence of lung cancer did not explain the increased risk of stroke. Moreover, the higher incidence of stroke after pneumonectomy and lobectomy was consistent across age groups, sex, and several comorbidities, including lung cancer. In addition, when compared with wedge resections, pneumonectomy, or lobectomy were associated with increased risk of stroke in the first 30 days after surgery.
Pneumonectomy, Lobectomy, and Risk of Stroke
In this study, lobectomy or pneumonectomy was associated with an increased risk of stroke compared with both a background population and patients with lung cancer without lobectomy/pneumonectomy. Compared with patients who underwent wedge resections, lobectomy/pneumonectomy was also associated with increased risk of stroke; however, in patients with lung cancer, this increased risk was not significant. Notably, both numbers of wedge resections and strokes were small among patients with lung cancer and may explain the insignificant association. In line with our findings, case reports and 1 small retrospective cohort study have suggested that thrombus formation in the pulmonary vein stump may cause embolization of vital organs after lobectomy and pneumonectomy. 3, 4, 6, 12 A cohort study among 193 patients who underwent lobectomy revealed that thrombus formation occurred overall in 3.6% and in 13.5% of patients with upper left lobectomy. 4 Moreover, a recent study of 562 patients who underwent lobectomy identified 6 patients (1%) with stroke within 30 days after lobectomy, and a thrombosis in the left superior vein stump was verified by contrast-enhanced computed tomography. 12 This incidence of stroke is largely in line with our results. In addition, we found that the risk of stroke was highest in the first 30 days after pneumonectomy and lobectomy and no longer elevated after 1 year. This finding is in line with 1 small previous study showing that thrombus formation may be a rather early phenomenon after surgery and that thrombi tend to disappear. 4 Patients undergoing lobectomy/pneumonectomy are a rather unique population in terms of both expected survival and comorbidities. The comparison to background population may be biased by a high burden of comorbidity and lifestyle-related risk factors among patients undergoing lobectomy/pneumonectomy. Similarly, patients with lung cancer who are not operated or offered only wedge resection may suffer from diffuse metastatic lung cancer or have other significant comorbidities precluding surgery. Despite this, lobectomy/pneumonectomy remained a risk factor for stroke in patients with lung cancer, compared with background population controls. Univariate and multivariate Poisson regression of risk of stroke for time at risk after pneumonectomy or lobectomy compared without pneumonectomy or lobectomy. A, overall and (B) stratified on atrial fibrillation and (C) stratified on atrial fibrillation in a subgroup of patients with lung cancer. Multivariable models adjusted for age, sex, calendar year, hypertension, peripheral artery disease, ischemic heart disease, heart failure, anticoagulant therapy, and chronic obstructive pulmonary disease and for A and B metastatic cancer and nonmetastatic cancer. IR indicates incidence rate; IRR, incidence rate ratio; and PY, person-years.
Atrial Fibrillation
Atrial fibrillation is common after lobectomy with 10% to 30% experiencing postoperative arrhythmias. 10, 20 Left-sided lobectomy is in itself a risk factor for atrial fibrillation, 23 and our findings could, therefore, be explained by cerebral infarction caused by unrecognized atrial fibrillation rather than thrombus formation in the pulmonary vein stump. In addition, atrial fibrillation has proven not to be a risk factor for thrombosis formation in the pulmonary vein stump. 4, 24 When stratified on atrial fibrillation, pneumonectomy and lobectomy increased the risk of stroke significantly during day 0 to 30 in both patients with and without atrial fibrillation, whereas this association only persisted throughout the first year in patients without atrial fibrillation. Stroke may be the first symptom in atrial fibrillation and, therefore, be the underlying cause even when atrial fibrillation did precede stroke after lobectomy or pneumonectomy. However, moving the date of first diagnosis of atrial fibrillation 60 days forward did not affect our results. Still, we cannot reject the hypothesis that transient unrecognized atrial fibrillation in the first 30 days after lobectomy or pneumonectomy could explain our findings.
Cancer and Risk of Stroke
Importantly, cancer is in itself is a risk factor for thrombus formation. 25 As lung cancer is the predominant indication for lobectomy or pneumonectomy, cancer may explain the high incidence of stroke after pneumonectomy and lobectomy. In general, the knowledge of pathophysiology behind the increased risk of stroke in patients with cancer is scarce, and the impact of pneumonectomy or lobectomy on this association is unknown. Including cancer and metastatic cancer in our models did not alter our findings. Furthermore, in subgroup analysis including only patients with lung cancer, pneumonectomy, and lobectomy remained a significant risk factor for stroke, indicating that risk factors for stroke associated with in particular lung cancer may not explain the increased risk. Lastly, when compared with wedge resection in a background population, pneumonectomy or lobectomy remained a risk factor for stroke, indicating that pneumonectomy and lobectomy and not lung surgery in itself are independent risk factors for stroke. It is a limitation that, few patients with lung cancer underwent wedge resection, which made the comparison between wedge resection and lobectomy/pneumonectomy in patients with lung cancer difficult to interpret.
Risk Factors for Stroke After Lobectomy
Case reports have mainly reported embolic incidents after upper left lobectomy, and the 2 existing cohort studies also identified left upper lobectomy as a risk factor for stroke 4, 12 It has been hypothesized that the length and anatomy of in particular the left upper pulmonary vein stump may dispose to thrombus formation. In 1 case report, a histopathologic analysis of a cerebral thrombus from the pulmonary vein stump proposed an interplay between 2 pathophysiological mechanisms: blood congestion in a relatively long pulmonary vein stump in combination with an inflammatory response to surgery. 26 After pneumonectomy or lobectomy, the upper left pulmonary vein stump is longer compared with the other. 26 Also, blood flow has been shown to be slower in the left pulmonary vein stump using ultrasound, compared with the right pulmonary vein, which could be a possible explanation for the higher risk among patients with left-sided lobectomy/pneumonectomy. 27 However, side of surgery was only registered in 50% of cases, and we were, Figure 2 . Multivariate Poisson regression of risk of stroke after pneumonectomy or lobectomy compared with wedge resection in patients without atrial fibrillation stratified on time since surgery. Model adjusted for age, sex, calendar year, hypertension, peripheral artery disease, ischemic heart disease, heart failure, anticoagulant therapy, and chronic obstructive pulmonary disease. *NA, not available, due to legislation in accordance with the policy of Statistics Denmark that does not allow report of personally identifiable data, that is, a low number. IR indicates incidence rate; IRR, incidence rate ratio; and PY, person-years.
therefore, not able to investigate the left side dominance in our study population.
Strengths and Limitations
Strengths of this study include the nationwide design, large population, and access to a wide range of data linked on individual level.
However, because of the observational character, we cannot impose causality between pneumonectomy or lobectomy and stroke. Through registries, pulmonary vein stump thrombosis was not registered, and based on our results, we are not able to conclude that the underlying cause of the observed increased risk of stroke is caused by pulmonary vein stump thrombosis.
A potential source of information bias includes misclassification of the specific type of surgery. However, we have no reason to think that systematic flawed registration should be present. Similarly, the large amount of missing data on the side of surgery represents a potential source of information bias; therefore, we did not include these factors in our analysis. However, the risk of stroke after upper left lobectomy or lobectomy may be higher than reported in this study.
Unmeasured confounding may be a potential source of bias. The lung cancer patient population consist of patients with an increased prevalence of smoking, possibly alcohol consumption, and hereby an overweight of lifestyle-related risk factors, all associated with an increased risk of stroke. Unfortunately, we do not have information on these lifestylerelated factors through our registries. Importantly, this association persisted in patients with lung cancer, and when adjusting for comorbidities highly correlated to lifestyle, including chronic obstructive pulmonary disease, diabetes mellitus, ischemic heart disease, and peripheral artery disease, pneumonectomy and lobectomy remained a risk factor for stroke. Lastly, we do not know whether an association between unmeasured cancer-related factors, type of chemotherapy, and risk of stroke affects our findings. However, our findings persisted when we included cancer and even metastatic cancer in our multivariable models.
Conclusions
The present study showed a markedly increased 0-to 30-day risk of stroke in patients who underwent pneumonectomy or lobectomy relative to patients undergoing wedge resections, as well as to background population controls. These findings were consistent among patients with lung cancer and in other subgroups, including age, sex, and comorbidities. Screening for stump vein thrombosis is not a standard of care after these surgeries. The results of this study justify further studies to clarify whether these patients should be Univariate and multivariate Poisson regression of risk of arterial embolization for time at risk after pneumonectomy or lobectomy compared with time without pneumonectomy or lobectomy. Multivariable model adjusted for age, sex, calendar year, hypertension, peripheral artery disease, ischemic heart disease, heart failure, anticoagulant therapy, chronic obstructive pulmonary disease, metastatic cancer, and nonmetastatic cancer. IR indicates incidence rate; IRR, incidence rate ratio; and PY, person-years. offered anticoagulation or screening or if the risk of stump vein thrombosis can be reduced by changing the surgery procedure. Overall, our findings indicate that possible pathogenesis, causal mechanisms, and preventive measures for stroke after pneumonectomy and lobectomy are highly warranted and should be explored in future prospective trials.
